Cooper Companies, Inc. (The) Declares Semiannual Dividend of $0.03 (NYSE:COO)
Cooper Companies, Inc. (The) (NYSE:COO) declared a semiannual dividend on Friday, July 7th, Wall Street Journal reports. Shareholders of record on Friday, July 21st will be given a dividend of 0.03 per share by the medical device company on Monday, August 7th. This represents a yield of 0.02%. The ex-dividend date is Wednesday, July 19th.
Cooper Companies, Inc. (The) has a dividend payout ratio of 0.6% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Cooper Companies, Inc. (The) to earn $10.61 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 0.6%.
Shares of Cooper Companies, Inc. (NYSE COO) traded down 0.43% during trading on Tuesday, hitting $243.59. The stock had a trading volume of 148,817 shares. The stock has a 50-day moving average price of $245.16 and a 200 day moving average price of $212.73. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The company has a market cap of $11.90 billion, a P/E ratio of 36.52 and a beta of 0.61.
Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. The company had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.05 EPS. Equities analysts expect that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.
COO has been the topic of several research analyst reports. J P Morgan Chase & Co reissued a “neutral” rating and set a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $250.00 target price (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Saturday, June 3rd. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $243.00 price target for the company in a report on Tuesday, May 23rd. BMO Capital Markets reiterated a “buy” rating and issued a $255.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. set a $225.00 price target on Cooper Companies, Inc. (The) and gave the company a “hold” rating in a report on Saturday, June 3rd. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $242.00.
In other Cooper Companies, Inc. (The) news, Director Stanley Md Zinberg sold 816 shares of the company’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total value of $198,402.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Carol R. Kaufman sold 44,092 shares of the company’s stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $242.81, for a total transaction of $10,705,978.52. Following the completion of the transaction, the executive vice president now directly owns 60,419 shares of the company’s stock, valued at $14,670,337.39. The disclosure for this sale can be found here. Over the last quarter, insiders sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is owned by insiders.
About Cooper Companies, Inc. (The)
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.